Home Pharmaceuticals Molecular Modeling Market

Molecular Modeling Market Size, Share & Trends Analysis Report By Products (Software, Services), By Application (Drug Development, Drug Discovery), By End-User (Pharmaceutical and Biotechnology Companies, Research and Academic Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SRPH55609DR | Pages: 110

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Molecular Modeling Market Size Analysis
    1. Global Molecular Modeling Market Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Development
        1. By Value
      3. Drug Discovery
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Research and Academic Centers
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Development
        1. By Value
      3. Drug Discovery
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Research and Academic Centers
        1. By Value
    5. U.S.
      1. By Products
        1. Introduction
          1. Products By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Development
          1. By Value
        3. Drug Discovery
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Research and Academic Centers
          1. By Value
    6. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Development
        1. By Value
      3. Drug Discovery
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Research and Academic Centers
        1. By Value
    5. U.K.
      1. By Products
        1. Introduction
          1. Products By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Development
          1. By Value
        3. Drug Discovery
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Research and Academic Centers
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Development
        1. By Value
      3. Drug Discovery
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Research and Academic Centers
        1. By Value
    5. China
      1. By Products
        1. Introduction
          1. Products By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Development
          1. By Value
        3. Drug Discovery
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Research and Academic Centers
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Development
        1. By Value
      3. Drug Discovery
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Research and Academic Centers
        1. By Value
    5. UAE
      1. By Products
        1. Introduction
          1. Products By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Development
          1. By Value
        3. Drug Discovery
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Research and Academic Centers
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Development
        1. By Value
      3. Drug Discovery
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Research and Academic Centers
        1. By Value
    5. Brazil
      1. By Products
        1. Introduction
          1. Products By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Development
          1. By Value
        3. Drug Discovery
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Research and Academic Centers
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
  14. Competitive Landscape
    1. Molecular Modeling Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Simulations Plus Inc (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Cambridge Crystallographic Data Centre (England)
    3. Optibrium (UK)
    4. Cresset (UK)
    5. BioSolvelT GmbH (Germany)
    6. OpenEye Scientific Software (US)
    7. Chemical Computing Group (Canada)
    8. Acellera Ltd (London)
    9. Dassault Systèmes (France)
    10. Schrödinger LLC (US).
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.